Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0aaecb2622856f602ec5e64c42bedcb8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
filingDate |
1997-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd8a0534641c133da47c18357353048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3dee749472a89f8335c7ae63a499ac9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09d5a24a5686c01495489bf3ab20b21e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eadbadbb211c04fe94225787c2d35f4b |
publicationDate |
2001-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HU-0004094-A2 |
titleOfInvention |
Physiologically acceptable aqueous b2000 substitute solutions |
abstract |
Physiologically acceptable aqueous solutions and methods for their use are provided. The subject solutions comprise: electrolytes; a dymamic buffering system and an oncotic agent; and do not comprise a conventional biological buffer. The subject solutions find use in a variety of applications, particularly in those applications where at least a portion of a host's blood volume is replaced with a blood substitute. |
priorityDate |
1997-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |